30 years of experience in CNS drug development – The fastest track from molecule to clinic
Expertise in CNS diseases
-
-
Alzheimer’s disease
-
Parkinson’s disease
-
Orphan neurodegenerative disorders
-
Cerebrovascular diseases
-
Psychiatric diseases
-
Profound knowledge of requirements
-
-
Pharmacology
-
ADME
-
Toxicology
-
Regulatory issues (IND/ CTA)
-
Clinical trials
-
Full coverage of client needs
Designing most efficient individualized development plan
Providing an outstanding network of KOLs in different fields of CNS diseases
Fastest reaction time
Competitive pricing
WE KNOW WHAT YOU NEED
BECAUSE WE DID IT ALREADY
MORE THAN ONCE
WE KNOW WHAT YOU NEED
BECAUSE WE DID IT ALREADY
MORE THAN ONCE
Our service is expertise
We understand drug targets and mechanisms of action
We know about challenges for a CNS compound
We have experience in translational research ,
Years of experience in academia, pharmaceutical and CRO industry and
Practical experience with:
- Neuronal tissue culture
- Induced and transgenic disease models
- Drug metabolism and Pharmacokinetics
- Safety pharmacology and toxicology
- Clinical trials – Biomarkers – Imaging – Neuropsychological testing
WE ARE DEDICATED TO YOUR SUCCESS
Aquila CTPV
Because safety comes first !
By using Aquila CTPV in your trial, you have taken a huge leap into the future of automated safety reporting, medical case reviewing and efficient data handling.
Meet your Experts
Leading CNS for decades
With well over 25 years in Neuroscience and 40+ years in research, our network contains eminent authorities in the field of Neuroscience, Alzheimers and overall CNS. This way we can ensure:
- Fastest reaction time
- Competetive Pricing
- Most reliable Service providers
- Most efficient individualized development plans